Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.


Results 51-60 of 99 (Search time: 0.004 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2013Phase III randomized, placebo-controlled study of cetuximab plus brivanib alaninate versus cetuximab plus placebo in patients with metastatic, chemotherapy-refractory, wild-type K-RAS colorectal carcinoma: The NCIC clinical trials group and AGITG co.Siu, L.; Shapiro, J.; Jonker, D.; Karapetis, C.; Zalcberg, J.; Simes, J.; Couture, F.; Moore, M.; Price, T.; Siddiqui, J.; Nott, L.; Charpentier, D.; Liauw, W.; Sawyer, M.; Jefford, M.; Magoski, N.; Haydon, A.; Walters, I.; Ringash, J.; Tu, D.; et al.
2015Endovascular therapy for ischemic stroke with perfusion-imaging selectionCampbell, B.; Mitchell, P.; Kleinig, T.; Dewey, H.; Churilov, L.; Yassi, N.; Yan, B.; Dowling, R.; Parsons, M.; Oxley, T.; Wu, T.; Brooks, M.; Simpson, M.; Miteff, F.; Levi, C.; Krause, M.; Harrington, T.; Faulder, K.; Steinfort, B.; Priglinger, M.; et al.
2019Enzalutamide with standard first-line therapy in metastatic prostate cancerDavis, I.D.; Martin, A.J.; Stockler, M.R.; Begbie, S.; Chi, K.N.; Chowdhury, S.; Coskinas, X.; Frydenberg, M.; Hague, W.E.; Horvath, L.G.; Joshua, A.M.; Lawrence, N.J.; Marx, G.; McCaffrey, J.; McDermott, R.; McJannett, M.; North, S.A.; Parnis, F.; Parulekar, W.; Pook, D.W.; et al.
2008Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is active in patients with imatinib-resistant or -intolerant accelerated-phase chronic myelogenous leukemiale Coutre, P.; Ottmann, O.; Giles, F.; Kim, D.; Cortes, J.; Gattermann, N.; Apperley, J.; Larson, R.; Abruzzese, E.; O'Brien, S.; Kuliczkowski, K.; Hochhaus, A.; Mahon, F.; Saglio, G.; Gobbi, M.; Kwong, Y.; Baccarani, M.; Hughes, T.; Martinelli, G.; Radich, J.; et al.
2012Pemetrexed versus pemetrexed and carboplatin as second-line chemotherapy in advanced non-small-cell lung cancer: Results of the GOIRC 02-2006 randomized phase II study and pooled analysis with the NVALT7 trialArdizzoni, A.; Tiseo, M.; Boni, L.; Vincent, A.; Passalacqua, R.; Buti, S.; Amoroso, D.; Camerini, A.; Labianca, R.; Genestreti, G.; Boni, C.; Ciuffreda, L.; Di Costanzo, F.; De Marinis, F.; Crino, L.; Santo, A.; Pazzola, A.; Barbieri, F.; Zilembo, N.; Colantonio, I.; et al.
2011A novel recurrent mutation in MITF predisposes to familial and sporadic melanomaYokoyama, S.; Woods, S.; Boyle, G.; Aoude, L.; MacGregor, S.; Zismann, V.; Gartside, M.; Cust, A.; Haq, R.; Harland, M.; Taylor, J.; Duffy, D.; Holohan, K.; Dutton-Regester, K.; Palmer, J.; Bonazzi, V.; Stark, M.; Symmons, J.; Law, M.; Schmidt, C.; et al.
2014Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanomaAoude, L.; Pritchard, A.; Robles-Espinoza, C.; Wadt, K.; Harland, M.; Choi, J.; Gartside, M.; Quesada, V.; Johansson, P.; Palmer, J.; Ramsay, A.; Zhang, X.; Jones, K.; Symmons, J.; Holland, E.; Schmid, H.; Bonazzi, V.; Woods, S.; Dutton-Regester, K.; Stark, M.; et al.
2021γδ T cells in merkel cell carcinomas have a proinflammatory profile prognostic of patient survivalGherardin, N.A.; Waldeck, K.; Caneborg, A.; Martelotto, L.G.; Balachander, S.; Zethoven, M.; Petrone, P.M.; Pattison, A.; Wilmott, J.S.; Quiñones-Parra, S.M.; Rossello, F.; Posner, A.; Wong, A.; Weppler, A.M.; Shannon, K.F.; Hong, A.; Ferguson, P.M.; Jakrot, V.; Raleigh, J.; Hatzimihalis, A.; et al.
2021Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019Feigin, V.L.; Stark, B.A.; Johnson, C.O.; Roth, G.A.; Bisignano, C.; Abady, G.G.; Abbasifard, M.; Abbasi-Kangevari, M.; Abd-Allah, F.; Abedi, V.; Abualhasan, A.; Abu-Rmeileh, N.M.; Abushouk, A.; Adebayo, O.M.; Agarwal, G.; Agasthi, P.; Ahinkorah, B.O.; Ahmad, S.; Ahmadi, S.; Salih, Y.A.; et al.
2015Serum levels of human MIC-1/GDF15 vary in a diurnal pattern, do not display a profile suggestive of a satiety factor and are related to BMITsai, V.; Macia, L.; Feinle-Bisset, C.; Manandhar, R.; Astrup, A.; Raben, A.; Lorenzen, J.; Schmidt, P.; Wiklund, F.; Pedersen, N.; Campbell, L.; Kriketos, A.; Xu, A.; Zhou, P.; Jia, W.; Curmi, P.; Angstmann, C.; Lee-Ng, K.; Zhang, H.; Marquis, C.; et al.; Young, M.